| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8987 |
| Human Intestinal Absorption | HIA+ | 0.9939 |
| Caco-2 Permeability | Caco2+ | 0.7783 |
| P-glycoprotein Substrate | Non-substrate | 0.6593 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8499 |
| Non-inhibitor | 0.9650 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7973 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9201 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7869 |
| CYP450 2D6 Substrate | Non-substrate | 0.8719 |
| CYP450 3A4 Substrate | Non-substrate | 0.5341 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6243 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7019 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9594 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7803 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9439 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6186 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9515 |
| Non-inhibitor | 0.9424 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.8404 |
| Fish Toxicity | High FHMT | 0.9401 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9925 |
| Honey Bee Toxicity | High HBT | 0.6657 |
| Biodegradation | Not ready biodegradable | 0.6465 |
| Acute Oral Toxicity | III | 0.7168 |
| Carcinogenicity (Three-class) | Non-required | 0.6205 |